Treatment
Treatment clinical trials
We’re tracking 8,469 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07206108Recruiting
Crown vs post-core for large tooth repairs after root canal
This trial compares two ways to fix large holes in premolars after root canal treatment: a modified crown attached to the remaining tooth, or a personalized post-and-crown. It looks for people with good oral health whose tooth has enough strong structure left for a successful repair.
ChinaAges 18–65 - NCT07208019Recruiting
Electroacupuncture for memory and thinking after stroke
This study tests whether electroacupuncture (using tiny electric pulses through thin needles) can help improve memory, focus, and thinking after a stroke. If you have mild to moderate thinking problems after a stroke, this treatment may help support your recovery.
Hangzhou, ZhejiangAges 35–80 - NCT07208097Recruiting
Brain bleed clot dissolving with tNK for stroke recovery
This trial tests a clot-busting drug called tenecteplase given directly into the brain bleed through a thin tube. It may help reduce damage and improve recovery for people with a certain type of brain hemorrhage.
Suzhou, AnhuiAges 18–80 - NCT07208643Recruiting
Long-term stability of dental implant infection treatments
This study checks if previous treatments for peri-implantitis (infection around dental implants) stay effective after 3 years. It follows patients who already finished a prior clinical trial comparing surgical and non-surgical treatments.
Sant Cugat del Vallès, BacelonaAges Any age - NCT07208981RecruitingPhase 2
Orelabrutinib, zebetuzumab, and lenalidomide for new MZL
This trial tests a combination of three drugs (orelabrutinib, zebetuzumab, and lenalidomide) for people newly diagnosed with a type of lymphoma called marginal zone lymphoma (MZL). If you qualify, you may receive this treatment to help control the disease.
Nanjing, JiangsuAges 18–75 - NCT07209189RecruitingPhase 2
Chemo and immunotherapy before surgery for head and neck cancer
This trial tests a combination of chemotherapy and an immunotherapy drug called Toripalimab before surgery for certain head and neck cancers. The goal is to see if this approach can reduce the extent of treatment needed while still being effective.
Baltimore, MarylandAges 18 years+ - NCT07209358Recruiting
Study of a new treatment for diabetic foot ulcers
This trial tests a new product (EDX110) to help heal diabetic foot ulcers that haven't improved with standard care. It's for people with diabetes who have a non-infected or mildly infected ulcer on their foot.
Phoenix, ArizonaAges 18–90 - NCT07209371RecruitingPhase 2
Rifaximin for IgA MGUS Treatment Trial
This trial tests if the antibiotic rifaximin can help treat a precancerous blood condition called IgA MGUS. Researchers want to see if targeting gut bacteria might slow or stop the progression of the disease.
Seattle, WashingtonAges 18 years+ - NCT07209488Recruiting
Reading help after stroke
This study is for people who have trouble reading after a left-brain stroke. It tests a new way to help improve reading skills through practice and therapy.
Tallahassee, FloridaAges 18–85 - NCT07209761RecruitingPhase 3
New drug combo for drug-resistant TB (quabodepistat)
This study tests a new oral medication combination (quabodepistat with other drugs) for people with drug-resistant pulmonary TB. It aims to find a shorter, safer, and more effective treatment.
Beijing, Beijing MunicipalityAges 14 years+ - NCT07210086RecruitingPhase 2
PET scans to guide radiation for limited metastatic prostate cancer
This trial uses a special PET scan (POSLUMA) before and after radiation to see if it helps treat prostate cancer that has spread to a few spots outside the pelvis. It's for men whose cancer still responds to hormone therapy and who have not had widespread spread.
Duarte, CaliforniaAges 18 years+ - NCT07210359Recruiting
New treatment for immature teeth
This trial tests a regenerative treatment for immature permanent teeth (front teeth with developing roots) in children and teens. The goal is to help the tooth's pulp heal and allow the root to continue growing naturally.
Kafr ash Shaykh, Kafr ElsheikhAges 9–15 - NCT07210580Recruiting
Tracking symptoms to improve quality of life for veterans with IBD
This study tests whether a structured approach to tracking symptoms and adjusting care (called measurement-based care) can improve quality of life for veterans with IBD. It is for veterans whose IBD symptoms affect their daily life and who receive care at one of the four participating VA hospitals.
Decatur, GeorgiaAges 18 years+ - NCT07210671Recruiting
Study on treating vein clots in cancer patients
This study looks at how to best treat blood clots in veins near the skin in people who also have active cancer. It will compare different treatment options to find what works best and is safest for you.
AmiensAges 18 years+ - NCT07210775RecruitingPhase 1/Phase 2
Imiquimod cream for mouth precancer
This trial tests a cream called imiquimod for people who have been diagnosed with oral dysplasia, a precancerous condition in the mouth. It is an option for those who cannot or choose not to have surgery or laser treatment.
Los Angeles, CaliforniaAges 18 years+ - NCT07211243Recruiting
Comparing two dressings for infected leg ulcers
This trial tests if a new version of a special dressing (Suprasorb X+PHMB Pro) works better than the current version for treating infected venous leg ulcers. It may help people with mildly to moderately draining wounds that are infected.
BialystokAges 18 years+ - NCT07211386Recruiting
Nerve block for severe cancer-related abdominal pain
This study tests whether a nerve block, called an erector spinae plane block, can reduce severe abdominal pain in people with gastrointestinal cancer who come to the emergency room. If you have cancer in your digestive system and are in pain that isn't controlled, this trial may help.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07211711Recruiting
Splint therapy for tinnitus linked to jaw joint issues
This trial tests if a custom mouthpiece (occlusal splint) can relieve ringing in the ears (tinnitus) that started along with jaw or face pain (TMD). It aims to see if stabilizing the jaw helps reduce both the noise in your ears and the discomfort.
São Paulo, São PauloAges 18 years+ - NCT07212335RecruitingEarly Phase 1
Stem cells for low blood counts after CAR-T
This trial tests if umbilical cord stem cells can help restore low blood counts in people with leukemia, lymphoma, or myeloma who still have low blood cell levels three weeks after CAR-T therapy. It aims to improve recovery and reduce infection or bleeding risks.
TianjinAges 18 years+ - NCT07214207RecruitingPhase 2
Testing a sleep medicine for alcohol use disorder and stress-related drinking
This trial tests whether a medicine called suvorexant, which is used for sleep, can help people with alcohol use disorder drink less, especially when stressed. You would receive the medicine or a placebo, and researchers will track your drinking and stress levels over several weeks.
Columbus, OhioAges 18–65 - NCT07214233Recruiting
Youth empowerment and safety study for LGBTQ+ teens
This trial tests a program to help sexual and gender minority youth (ages 12-17) who have been involved with systems like juvenile justice or mental health services and have had thoughts of self-harm. It includes a caregiver to support the teen.
Cleveland, OhioAges 12–17 - NCT07214246Recruiting
Follicular fluid microRNAs in egg health and aging
This study looks at tiny molecules in the fluid around your eggs that may explain how age affects fertility. By joining, you help scientists understand egg health and may get insights from your own IVF treatment.
Orlando, FloridaAges 18 years+ - NCT07214298RecruitingPhase 1/Phase 2
Combination study of pegcetacoplan and FOLFIRINOX for metastatic pancreatic cancer
This trial tests a new drug called pegcetacoplan combined with a standard chemotherapy regimen (FOLFIRINOX) for people with pancreatic cancer that has spread. The goal is to see if adding pegcetacoplan makes the treatment more effective.
Buffalo, New YorkAges 18 years+ - NCT07214532Recruiting
Guiding CDK4/6 inhibitor use by a blood test in breast cancer
This trial is for women and men with early-stage, hormone-positive, HER2-negative breast cancer. It uses a blood test (Signatera) to detect tiny amounts of cancer DNA and only starts a CDK4/6 inhibitor (ribociclib or abemaciclib) if the test shows cancer DNA is present.
Birmingham, AlabamaAges 18 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,469 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.